SCHEMBL19972777

SCHEMBL19972777

CC(C)C(CO)NC(=O)C1Cc2ccccc2CN1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.54
OPRD1 P41143 3/20 0.54
OPRK1 P41145 3/20 0.54
SMYD3 Q9H7B4 1/20 0.52
KCNH2 Q12809 6/20 0.52
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
POLB P06746 1/20 0.46
PRMT5 O14744 1/20 0.46
WDR77 Q9BQA1 1/20 0.46
MAPK8 P45983 1/20 0.44
MAPK9 P45984 1/20 0.44
MAPK10 P53779 1/20 0.44
CXCR3 P49682 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19972775 1.00 OPRM1 (0.54) OPRM1OPRD1OPRK1SMYD3KCNH2
SCHEMBL21294368 0.85 KCNH2 (0.63) OPRM1OPRD1OPRK1KCNH2MAPK8
SCHEMBL29484945 0.85 KCNH2 (0.63) OPRM1OPRD1OPRK1KCNH2MAPK8
SCHEMBL19972748 0.85 KCNH2 (0.63) OPRM1OPRD1OPRK1KCNH2MAPK8
SCHEMBL19972778 0.83 KMT2A (0.50) OPRM1OPRD1OPRK1SMYD3KCNH2
SCHEMBL29744520 0.83 KMT2A (0.50) OPRM1OPRD1OPRK1SMYD3KCNH2
SCHEMBL19972776 0.83 KMT2A (0.50) OPRM1OPRD1OPRK1SMYD3KCNH2
SCHEMBL31037193 0.82 OPRM1 (0.57) OPRM1OPRD1OPRK1SMYD3KCNH2
SCHEMBL6368127 0.82 OPRM1 (0.57) OPRM1OPRD1OPRK1SMYD3KCNH2
SCHEMBL21739210 0.79 OPRM1 (0.39) OPRM1OPRD1OPRK1SMYD3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512832-A1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS Research Triangle Institute, International (US) 2019-07-24 EP disclosed
WO-2018053222-A1 TETRAHYDROISOQUINOLINE KAPPA OPIOID ANTAGONISTS RESEARCH TRAINGLE INSTITUTE (US) 2018-03-22 WO disclosed